Dr Stevens promoted from Director of Drug Discovery, and Dr Kirby promoted from Director of Operations
Cambridge, UK, 06 July 2023: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointments of Dr Robert Kirby to Chief Operating Officer and Dr Edward Stevens to Chief Scientific Officer. Both appointments represent promotions from within the company.
Life Sciences industry entrepreneur joins the region’s Life Science & Healthcare membership organisation
Here are four interesting insights from the report:
• Amid inflation, talent shortages and other disruption, savvy biotech’s are focusing on the fundamentals of preserving cash and producing strong data and evidence to showcase their overall resilience to potential investors.
• In light of the recently passed Inflation Reduction Act and its impact on drug pricing, inflationary rebates and Medicare Part D redesign, biotech leaders need to take a strategic approach around commercialization, launch sequencing and other areas.
IPO Quarterly Report
In Q2 2023, emerging markets are thriving amid a slow global IPO market.
In brief
• In the first half of 2023, global IPO volumes fell 5%, with proceeds down 36% YOY.
• The US had its largest offering since November 2021.
• Asia-Pacific continues to dominate with an approximate 60% share of global IPOs.
28 June 2023 - Private equity buyouts in the UK healthcare sector including life sciences increased 14%* in Q1 2023 and remain ahead of pre-pandemic levels, even in the face of economic headwinds. With high levels of capital available to be deployed, its expected private equity interest will continue to be elevated, says RSM UK.
July's eNews is here to help you unveil the latest insights for advancing our Life Science Cluster!
• Pioneering partnership will see the delivery of 95,000 square feet of incubator space on the South Bank of London
• Split across two sites, the life sciences facilities will help incubate early-stage companies spun out of King’s College London in a boost for UK life sciences
• Announcement comes just weeks after the government launched a package of measures to turbocharge growth in UK life sciences
Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR ANNOUNCES ADDITIONAL AGREEMENT WITH LEADING BIOPHARMACEUTICAL COMPANY
Cambridge, UK, 5 July 2023. Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that it has entered into an agreement with a leading biopharmaceutical company to support the ongoing development of a biosimilar product.
Members of the Domainex team supported their local community by volunteering at Sawston Village College. They helped to paint fences, build raised flower beds and did plenty of weeding! Check out the team photo on the Domainex Twitter page!
The DIAMOND Study
The Quadram Institute are looking for volunteers, based in the UK, to take part in a study investigating how our genes and diet influence the risk of dementia, and the role of the gut microbiome in this.
This study can be carried out fully remotely from your own home.